Cardiovascular instability preceded by orolingual angioedema after alteplase treatment

Internal Medicine

Volumn 55, Issue 4, 2016, Pages 409-412

  Kageyama, Takashi ^a   Okanoue, Yusuke ^a   Takai, Rieko ^a   Suenaga, Toshihiko ^a  

^a TENRI HOSPITAL   (Japan)

Author keywords

Alteplase; Bradykinin; Cerebral infarction; Orolingual angioedema; Rt PA

Indexed keywords

ALTEPLASE; HYDROCORTISONE; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ANGIONEUROTIC EDEMA; ARTICLE; ATAXIC APHASIA; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR INSTABILITY; CASE REPORT; DYSARTHRIA; HEART HEMODYNAMICS; HEMIPARESIS; HUMAN; HYPOTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OROLINGUAL ANGIOEDEMA; TONGUE BLEEDING; VERY ELDERLY; APHASIA, BROCA; BRAIN CORTEX; CHEMICALLY INDUCED; DISEASE COURSE; FRONTAL LOBE; MOUTH; PARESIS; PATHOLOGY; TONGUE; TREATMENT OUTCOME;

AGED, 80 AND OVER; ANGIOEDEMA; ANTI-INFLAMMATORY AGENTS; ANTIHYPERTENSIVE AGENTS; APHASIA, BROCA; CEREBRAL CORTEX; DISEASE PROGRESSION; DYSARTHRIA; FIBRINOLYTIC AGENTS; FRONTAL LOBE; HUMANS; HYDROCORTISONE; MAGNETIC RESONANCE IMAGING; MALE; MOUTH; PARESIS; TISSUE PLASMINOGEN ACTIVATOR; TONGUE; TREATMENT OUTCOME;

EID: 84958183159     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.55.4772     Document Type: Article

References (17)

1. Hill MD, Lye T, Moss H, et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 60: 1525-1527, 2003.
2. Engelter ST, Fluri F, Buitrago-Téllez C, et al. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol 252: 1167-1170, 2005.
3. Molinaro G, Gervais N, Adam A. Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach. Stroke 33: 1712-1716, 2002.
4. Kaplan AP, Joseph K, Shibayama Y, et al. Bradykinin formation. Plasma and tissue pathways and cellular interactions. Clin Rev Allergy Immunol 16: 403-429, 1998.
5. Cyr M, Lepage Y, Blais C Jr., et al. Bradykinin and des-Arg9-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol 281: H275-H283, 2001.
6. Molinaro G, Cugno M, Perez M, et al. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine9-bradykinin. J Pharmacol Exp Ther 303: 232-237, 2002.
7. Duan QL, Nikpoor B, Dube MP, et al. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet 77: 617-626, 2005.
8. Woodard-Grice AV, Lucisano AC, Byrd JB, Stone ER, Simmons WH, Brown NJ. Gender-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics 20: 532-536, 2010.
9. Hui Y, Wu Y, Tormey CA. The development of a novel molecular assay examining the role of aminopeptidase P polymorphisms in acute hypotensive transfusion reactions. Arch Pathol Lab Med 137: 96-99, 2013.
10. Cloutier F, Ongali B, Campos MM, Thibault G, Neugebauer W, Couture R. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontane- ously hypertensive rats. Br J Pharmacol 142: 285-296, 2004.
11. Ribuot C, Godin D, Couture R, Regoli D, Nadeau R. In vivo B2-receptor-mediated negative chronotropic effect of bradykinin in canine sinus node. Am J Physiol 265: H876-H879, 1993.
12. Oppenheimer SM, Gelb A, Girvin JP, Hachinski VC. Cardiovascular effects of human insular cortex stimulation. Neurology 42: 1727-1732, 1992.
13. Jing CH, Lou M, Wang JH, Ding MP. Acute insular infarct increases risk of electrocardiogram changes and sudden cardiac death. Zhejiang Da Xue Xue Bao Yi Xue Ban 39: 577-582, 2010 (in Chinese, Abstract in English).
14. Ferreira SH, Vane JR. The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat. Br J Pharmacol Chemother 30: 417-424, 1967.
15. Kulhari A, Strbian D, Sundararajan S. Early onset seizures in stroke. Stroke 45: e249-e251, 2014.
16. Lin SY, Tang SC, Tsai LK, et al. Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use. Eur J Neurol 21: 1285-1291, 2014.
17. Riedl M. Hereditary angioedema therapy: kallikrein inhibition and bradykinin receptor antagonism. World Allergy Organ J 3 (Suppl 9): S34-S38, 2010.